Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine
(2019) In Nature Biotechnology 37. p.513-518- Abstract
- On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these,... (More)
- On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/59ef8678-0965-4cd5-a42c-8d8869d8a356
- author
- Aboy, Mateo ; Crespo, Cristina ; Liddell, Kathleen ; Minssen, Timo LU and Liddicoat, Johnathan
- publishing date
- 2019-05-01
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Medical law, Medicinsk rätt
- in
- Nature Biotechnology
- volume
- 37
- pages
- 6 pages
- publisher
- Nature Publishing Group
- external identifiers
-
- scopus:85065185847
- ISSN
- 1087-0156
- DOI
- 10.1038/s41587-019-0111-5
- language
- English
- LU publication?
- no
- id
- 59ef8678-0965-4cd5-a42c-8d8869d8a356
- date added to LUP
- 2020-12-16 13:51:16
- date last changed
- 2022-04-26 22:36:55
@article{59ef8678-0965-4cd5-a42c-8d8869d8a356,
abstract = {{On the sixth year anniversary of Mayo (https://www.supremecourt.gov/opinions/11pdf/10-1150.pdf), our empirical study examines the impact of the US Supreme Court decision on patent subject-matter eligibility, patent examination and patent prosecution of biotech related patent applications before the USPTO. To answer our research questions, we developed an empirical methodology designed to elucidate Mayo’s impact on patent applications across a full technology center, TC 1600, which relates to Biotechnology & Organic Chemistry, as well as the narrower Art Unit 1634. Our search algorithm identified 72,990 USPTO correspondence documents that contained a Mayo citation over the last six years (20 March 2012 to 20 March 2018). Of these, 33,878 were identified in Examiner Office Actions, 34,417 in Applicant Responses to Office Actions and 4,695 in other correspondence, such as Appeals.}},
author = {{Aboy, Mateo and Crespo, Cristina and Liddell, Kathleen and Minssen, Timo and Liddicoat, Johnathan}},
issn = {{1087-0156}},
keywords = {{Medical law; Medicinsk rätt}},
language = {{eng}},
month = {{05}},
pages = {{513--518}},
publisher = {{Nature Publishing Group}},
series = {{Nature Biotechnology}},
title = {{Mayo’s impact on patent applications related to biotechnology, diagnostics and personalized medicine}},
url = {{http://dx.doi.org/10.1038/s41587-019-0111-5}},
doi = {{10.1038/s41587-019-0111-5}},
volume = {{37}},
year = {{2019}},
}